Patents by Inventor Flint Smith

Flint Smith has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5215743
    Abstract: Compositions are described that are suitable for formulating cytokines, preferably tumor necrosis factor, that maintain their biological activities over a wide range of temperatures by, among other aspects, decreasing them sensitivity to agitation, and preventing oligomer and particulate matter formation.
    Type: Grant
    Filed: April 13, 1988
    Date of Patent: June 1, 1993
    Inventors: Maninder Singh, Flint Smith
  • Patent number: 5162507
    Abstract: A process for recovering highly pure, recombinant IL-2 from transformed microorganisms in which the cells are disrupted; impure recombinant IL-2 is isolated in the form of refractile bodies from the disruptate; the impure IL-2 is dissolved and denatured with at least 6M guanidine hydrochloride containing a reducing agent; the reduced IL-2 is precipitated and resolubilized; the reduced solubilized IL-2 therein is oxidized by a controlled oxidation; the oxidized IL-2 is refolded by reducing the concentration of guanidine hydrochloride in the solution; and the oxidized, refolded IL-2 is further purified by ion exchange chromatography or hydrophobic interaction chromatography and ion exchange chromatography.
    Type: Grant
    Filed: September 12, 1989
    Date of Patent: November 10, 1992
    Assignee: Cetus Corporation
    Inventors: Sidney N. Wolfe, Glenn J. Dorin, John T. Davis, Flint Smith, Amy Lim, Robert Weissburg
  • Patent number: 4931543
    Abstract: A process for recovering substantially pure rIL-2 from transformed microorganisms in which the cells are disrupted, impure insoluble rIL-2 is separated from the bulk of the cellular components, the separated impure rIL-2 is solubilized and partially purified in a reduced form, the solubilized rIL-2 is oxidized, the oxidized rIL-2 is purified to clinically acceptable levels, and the oxidized, purified IL-2 is denatured by placing it into a solution of a chaotropic agent, solids are removed from the solution and rIL-2 is renatured from the solution.
    Type: Grant
    Filed: March 25, 1988
    Date of Patent: June 5, 1990
    Assignee: Cetus Corporation
    Inventors: Robert Halenbeck, Flint Smith, Michael Kunitani
  • Patent number: 4203516
    Abstract: A novelty greeting card having front and rear panels hingedly connected by a spine section of finite width. A block having a thickness equal to the width of the spine and the same area as the back panel is secured to the front face of the back panel. A well formed in the central portion of the block and contains a dog biscuit.
    Type: Grant
    Filed: February 12, 1979
    Date of Patent: May 20, 1980
    Assignee: A. Bristol Corporation
    Inventors: Dorothea E. Stonoga, Virginia K. Flint-Smith